Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 10, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-24
DOI
10.1038/s41419-018-1040-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chlamydia trachomatis-containing vacuole serves as deubiquitination platform to stabilize Mcl-1 and to interfere with host defense
- (2017) Annette Fischer et al. eLife
- ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer
- (2017) Eun Young Kim et al. NEOPLASIA
- MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1
- (2016) Dezhi Cheng et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
- (2016) E. A. Punnoose et al. MOLECULAR CANCER THERAPEUTICS
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- An injectable nanoparticle generator enhances delivery of cancer therapeutics
- (2016) Rong Xu et al. NATURE BIOTECHNOLOGY
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor
- (2015) Y. Xiao et al. MOLECULAR CANCER THERAPEUTICS
- Oxidative Modification of miR-184 Enables It to Target Bcl-xL and Bcl-w
- (2015) Jian-Xun Wang et al. MOLECULAR CELL
- Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
- (2015) Joel D. Leverson et al. Science Translational Medicine
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- BH3 profiling in whole cells by fluorimeter or FACS
- (2013) Jeremy Ryan et al. METHODS
- BH3 Mimetics: Status of the Field and New Developments
- (2013) C. Billard MOLECULAR CANCER THERAPEUTICS
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Navitoclax Enhances the Efficacy of Taxanes in Non–Small Cell Lung Cancer Models
- (2011) Nguyen Tan et al. CLINICAL CANCER RESEARCH
- BIM Expression in Treatment-Naive Cancers Predicts Responsiveness to Kinase Inhibitors
- (2011) A. C. Faber et al. Cancer Discovery
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines
- (2010) H Zhang et al. ONCOGENE
- BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program
- (2010) D. Ren et al. SCIENCE
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now